Talk:Pegvisomant

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Pegvisomant.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Wiki Education Foundation-supported course assignment[edit]

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): KFunk740.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 06:19, 17 January 2022 (UTC)[reply]

In the News[edit]

This drug is the subject of a current event: http://www.nytimes.com/2011/02/17/science/17longevity.html —Preceding unsigned comment added by 148.87.67.132 (talk) 01:55, 17 February 2011 (UTC)[reply]

Origin[edit]

John Kopchick discovered Pegvisomant in 1987, and it was approved by the FDA in 2003. This information should be included in this article. Here's an interesting source for that: http://www.ohio.edu/research/communications/royaltymonetization.cfm

 --Dulcimerist (talk) 21:05, 6 May 2012 (UTC)[reply]

Side Effects[edit]

Citations relatively outdated, and incomplete/inaccurate. See more extensive data in Acrostudy ^[1] KFunk740 (talk) 15:36, 19 October 2016 (UTC)[reply]

References

^ https://www.ncbi.nlm.nih.gov/pubmed/25370326

Other Uses[edit]

Pegvisomant can potentially inhibit growth of some types of tumors.,^[1]^[2] KFunk740 (talk) 15:46, 19 October 2016 (UTC)[reply]

References

General Comments[edit]

Overall structure is OK enough, but can be expanded quite a bit. I agree with Dulcimerist, that article needs a section on the drug discovery and linked to John Kopchick's wiki article, along with revenue data for Ohio University. Intro section needs to be clarified. It appears imbalanced toward lack of efficacy, but more recent data is more convincing that it does improve health and quality of life. Sources stated aren't reliable enough. (hopefully this gets a few more points on assignment). KFunk740 (talk) 00:14, 28 October 2016 (UTC)[reply]

[1] ttps://www.ncbi.nlm.nih.gov/pubmed/25370326

[2] ttps://www.ncbi.nlm.nih.gov/pubmed/27241667

[3] ttps://www.ncbi.nlm.nih.gov/pubmed/16541323

[1]

[1]

[2]